Skip to content


These condensed guidelines are provided to assist researchers in determining whether or not their research requires Institutional Biosafety Committee (IBC) approval. If so, the researcher should submit a registration form to the IBC. This abstract is not all inclusive and if the researcher is not sure if his/her program needs review, he/she should contact the IBC. Also, please see the IBC Classification Cheat Sheet and the complete NIH Guidelines for Research Involving Recombinant DNA Molecules for further details.

Those researchers proposing human gene therapy protocols must submit additional information. Specific points to consider can be found on a separate form available through Research Administration.


Last Published: Mar 12, 2021